Skip to Content
Merck

Adverse reactions of piroxicam.

Drug intelligence & clinical pharmacy (1987-09-01)
D Gerber
ABSTRACT

During the approximately five years (1981-86) that piroxicam has been available in South Africa, the Medicines Safety Centre has received 31 reports of adverse reactions associated with this drug. Among these are two reactions not previously recorded in the literature, paresthesia and hair loss. This article records drug events associated with piroxicam worldwide and tabulates those received by the Centre.

MATERIALS
Product Number
Brand
Product Description

USP
Piroxicam, United States Pharmacopeia (USP) Reference Standard
Piroxicam, European Pharmacopoeia (EP) Reference Standard
Piroxicam for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Piroxicam, ≥98% (TLC)
Sigma-Aldrich
Piroxicam, meets USP testing specifications